Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate in Ankylosing Spondylitis
NCT01038011Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risedronate in ankylosing spondylitis (AS), sponsored by University of Zurich. Started Jun 2004; status: completed.
02
Drugs
risedronate
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01038011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038011.